Genes & CellsGenes & CellsГены и КлеткиGenes and Cells2313-18292500-2562Human Stem Cells Institute200185Clinical TrialsКлинические испытанияResearch ArticleNew data on the effectiveness of liver cell transplantation in patients with Crigler-Najjar syndromeНовые данные об эффективности трансплантации клеток печени пациентам с синдромом Криглера - НайяраPlaksaI. L.ПлаксаИ. Л.bozo.ilya@gmail.com120420083424260702202307022023Copyright ©; 2023, Eco-VectorCopyright ©; 2023, Эко-Вектор2023Eco-VectorЭко-Векторhttps://genescells.ru/2313-1829/article/view/200185[Fox I.S., Chowdhury J.R., Kaufman S.S. et al. Treatment of the Crigler-Najjar syndrom type I with hepatocyte transplantation. Engl. J. Med. 1998; 338: 1422-6.][Kautman S.S., Wood R.P., Show P.W. jr., Markin R.S. Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology 1986; 6: 1259-62.][Sokal E.M., Silva E.S., Hermans D. Orthotopic liver transplantation for Crigler-Najjar type I disease in six children. Traspant. 1995; 60: 1035—58.][Evans H.M., Kelly D.A., Me Kierman P.S., Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109-17.][Makouka L., Falk J.A., Falk R.E. Allogenic intrasplenic hepatocyte transplantation. Transplant. Proc. 1987; 19: 1002—3.][Cubero E.S., Maganto P., Ortiz A. Hepatic proliferation in Gunn rats transplanted with hepatocytes. Cell Prolis. 2005; 38; 134-46.][Wu Y.M., Joseph B., Gupta S. Immunosupression using mTOR inhibition mechanism affects replacement of rat liver with transplanted cells. Hepatology 2006; 44: 410—9.][Dixit V., Darnasi R., Arthur M. et al. Cryopreserved microencapsulated hepatocytes-transplantation stadies in Gunn rats. Transplant. 1993; 55: 616—22.][Liu Z.C., Chang T.M. Coencapsulation of hepatocytes and bone marrow stem cells. Int. J. Artif. Organs 2003; 26: 491—7.]